Dr Reddy's slips 7% following 8 USFDA observations for Duvvada plant

The stock slipped 7% to Rs 2,425 on the BSE after the pharmaceutical company said US health regulator issued eight observations after inspecting its formulations plant at Duvvada, Visakhapatnam.

from Latest News https://ift.tt/2P0rckJ
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd

• Tweet
• Share
• Share
• Share
• Share